Effects of the Chinese herbal formula Shi-Bi-Lin on cytokine release from the human mast cell line
- PMID: 16095146
- DOI: 10.1016/S1081-1206(10)61192-1
Effects of the Chinese herbal formula Shi-Bi-Lin on cytokine release from the human mast cell line
Abstract
Background: The traditional Chinese herbal formula Cang Er Zi San has been used for the treatment of rhinitis, paranasal sinusitis, and allergic rhinitis for several centuries. However, its therapeutic mechanisms remain largely unclear.
Objective: To study the effects of Shi-Bi-Lin (SBL), a modified Cang Er Zi San formula, on cytokine release from and expressions in the human mast cell line (HMC-1).
Methods: The HMC-1 was preincubated with different concentrations of SBL extract solution 1 hour before being stimulated with 25 ng/mL of phorbol myristate acetate plus 2.5 x 10(-7)M calcium ionophore A23187 and then further incubated for 6, 12, and 24 hours, respectively. The cell culture supernatants were harvested, and the cytokines of interleukin 4 (IL-4), IL-6, IL-8, and tumor necrosis factor alpha (TNF-alpha) in the supernatants were measured by enzyme-linked immunosorbent assay. Furthermore, the total RNA of the cells was extracted, and the cytokines' messenger RNA expressions were examined using semiquantitative reverse transcriptase-polymerase chain reaction.
Results: After different incubation periods at different concentrations, SBL could potently inhibit the cytokines of IL-4 and TNF-alpha and modestly affect IL-6 but not obviously affect IL-8 release from the HMC-1. However, no inhibitory effects were detected on the messenger RNA expressions of these cytokines.
Conclusions: These results demonstrate that SBL could modulate the mast cell-mediated hypersensitivity reaction in allergy. Inhibition of mast cell-derived IL-4 and TNF-alpha might explain the efficacy of SBL in treating allergic disease.
Similar articles
-
The effects of Fructus Xanthii extract on cytokine release from human mast cell line (HMC-1) and peripheral blood mononuclear cells.Immunopharmacol Immunotoxicol. 2008;30(3):543-52. doi: 10.1080/08923970802135385. Immunopharmacol Immunotoxicol. 2008. PMID: 18618314
-
Libanoridin inhibits the mast cell-mediated allergic inflammatory reaction.Immunopharmacol Immunotoxicol. 2010 Jun;32(2):258-64. doi: 10.3109/08923970903279991. Immunopharmacol Immunotoxicol. 2010. PMID: 20100031
-
Inhibitory effect of Gamibojungikgitang extract on mast cell-mediated allergic reaction in murine model.J Pharm Pharm Sci. 2005 Apr 15;8(1):94-101. J Pharm Pharm Sci. 2005. PMID: 15946602
-
The influence of traditional herbal formulas on cytokine activity.Toxicology. 2010 Nov 28;278(1):140-59. doi: 10.1016/j.tox.2009.09.020. Epub 2009 Oct 7. Toxicology. 2010. PMID: 19818374 Review.
-
[Role of therapeutics for allergic diseases in targeting histamine H1 receptor gene expression].Yakugaku Zasshi. 2007 Jan;127(1):15-25. doi: 10.1248/yakushi.127.15. Yakugaku Zasshi. 2007. PMID: 17202781 Review. Japanese.
Cited by
-
Integrating 16S rRNA Sequencing, Microflora Metabolism, and Network Pharmacology to Investigate the Mechanism of SBL in Alleviating HDM-Induced Allergic Rhinitis.Int J Mol Sci. 2024 Aug 8;25(16):8655. doi: 10.3390/ijms25168655. Int J Mol Sci. 2024. PMID: 39201342 Free PMC article.
-
Complementary therapies in allergic rhinitis.ISRN Allergy. 2013 Nov 13;2013:938751. doi: 10.1155/2013/938751. eCollection 2013. ISRN Allergy. 2013. PMID: 24324897 Free PMC article.
-
Identifying the Chinese Herbal Medicine Network and Core Formula for Allergic Rhinitis on a Real-World Database.Evid Based Complement Alternat Med. 2020 Nov 5;2020:5979708. doi: 10.1155/2020/5979708. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33204289 Free PMC article.
-
Allergic rhinoconjunctivitis: complementary treatments for the 21st century.Curr Allergy Asthma Rep. 2009 Mar;9(2):121-7. doi: 10.1007/s11882-009-0018-1. Curr Allergy Asthma Rep. 2009. PMID: 19210901 Review.
-
Complementary therapy in allergic rhinitis.Curr Allergy Asthma Rep. 2008 Apr;8(2):118-25. doi: 10.1007/s11882-008-0021-y. Curr Allergy Asthma Rep. 2008. PMID: 18417053 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources